000 04100nam a22005175i 4500
001 978-94-007-0277-6
003 DE-He213
005 20140220083828.0
007 cr nn 008mamaa
008 110104s2011 ne | s |||| 0|eng d
020 _a9789400702776
_9978-94-007-0277-6
024 7 _a10.1007/978-94-007-0277-6
_2doi
050 4 _aQR251-255
072 7 _aMMFP
_2bicssc
072 7 _aMED103000
_2bisacsh
082 0 4 _a616.96
_223
100 1 _aJha, T.K.
_eeditor.
245 1 0 _aKala Azar in South Asia
_h[electronic resource] :
_bCurrent Status and Challenges Ahead /
_cedited by T.K. Jha, E. Noiri.
264 1 _aDordrecht :
_bSpringer Netherlands,
_c2011.
300 _aX, 290p.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
505 0 _aPreface -- Section 1: Introduction into Kala-Azar -- 1. Geography -- 2.  Pathology and Mechanism of Kala-azar & PKDL -- 3. Diagnosis and Treatment of Kala-azar & PKDL -- Section 2: Therapeutic Strategy to Deal with Emergence of Drug Resistance -- 4. Epidemiology of Drug-Resistant Kala-azar in India and neighboring countries -- 5. Therapeutic Strategy for treatment of VL in drug resistant regions -- 6. Need for combination therapy to control kala-azar in South Asia -- Section 3: Diagnostic Strategy Enhancing Kala-azar Elimination Program -- 7. Challenges to visceral leishmaniasis diagnosis in the Indian sub-continent -- 8. Potentiality of urinary tests to kala-azar disease management -- 9. Use of LAMP as a practical field tool for diagnosis of Kala-azar -- Section 4: PKDL and its Implications in Eliminating Kala-azar -- 10. Polymorphism of kala azar in South Asia -- 11. Post kala-azar dermal leishmaniasis (PKDL): Facing the challenge for eliminating kala-azar from South Asia -- Section 5: New challenges confronting Kala azar Elimination Programme and their possible solutions -- 12. Climate change and kala-azar -- 13. Role of policy makers in achieving the target for kala azar elimination in South Asia – the Bangladesh experience.
520 _aTherapeutic regimens for visceral leishmaniasis (also Kala-azar, Dum-dum fever or black fever), caused by parasitic protozoa of the Leishmania genus, evolve at a pace never seen before. Spread by tiny and abundant sand flies, the parasite infects internal organs and bone marrow and if left untreated will almost always result in the death of the host. In developing countries successful diagnosis and treatment are complicated by asymptomatic cases, undernutrition and Kala-azar/HIV co-infections. This book brings together world-renown experts writing state-of-arts review on the progress in diagnosis and treatment of visceral leishmaniasis, ultimately leading to the complete elimination of this fatal disease from South Asia. The chapters provide valuable information for disease control as well as therapy and the diagnostic improvements necessary for early treatment, subclinical detection and drug-resistant cases. The presented methods allow for points-of-care testing in the endemic area, enabling rapid detection in resource-poor settings with easy handling and low costs.  This book provides essential information for scientists, medical practitioners and policy makers involved in the diagnosis, treatment and elimination of Kala-azar.
650 0 _aMedicine.
650 0 _aMedical laboratories.
650 0 _aDrug interactions.
650 0 _aMedical parasitology.
650 0 _aNephrology.
650 0 _aVeterinary medicine.
650 1 4 _aBiomedicine.
650 2 4 _aParasitology.
650 2 4 _aDrug Resistance.
650 2 4 _aVeterinary Medicine.
650 2 4 _aLaboratory Medicine.
650 2 4 _aNephrology.
700 1 _aNoiri, E.
_eeditor.
710 2 _aSpringerLink (Online service)
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9789400702769
856 4 0 _uhttp://dx.doi.org/10.1007/978-94-007-0277-6
912 _aZDB-2-SBL
999 _c109242
_d109242